Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Revenue

Zealand Pharma had revenue of 34.00M DKK in the quarter ending March 31, 2026, with 325.00% growth. This brings the company's revenue in the last twelve months to 9.24B, up 16,519.65% year-over-year. In the year 2025, Zealand Pharma had annual revenue of 9.21B with 14,598.86% growth.

• Revenue (ttm): 9.24B
• Revenue Growth: +16,519.65%
• P/S Ratio: 2.48
• Revenue / Employee: 16.99M
• Employees: 544
• Market Cap: 22.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.21B	9.15B	14,598.86%
Dec 31, 2024	62.69M	-280.10M	-81.71%
Dec 31, 2023	342.79M	238.80M	229.65%
Dec 31, 2022	103.99M	-4.56M	-4.20%
Dec 31, 2021	108.55M	-83.46M	-43.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error